Talkingmedicines.com

Visit talkingmedicines.com
  • 5 months ago

    Last scanned

  • 9 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Talkingmedicines.com

Visit talkingmedicines.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

Home - Talking Medicines

Drug-GPT™ is revolutionizing the pharmaceutical industry. Talking Medicines uses AI and NLP to transform social feedback from patients, HCPs, KOLs, and DOLs into actionable insights for advertising agencies and their pharmaceutical clients. Harnessing the power of data science, our platform, powered by Drug-GPT™, provides a single source of truth about lived experiences, improving marketing ROI and patient health outcomes. Access real-time insigh...

Talkingmedicines.com thumbnail
Talkingmedicines.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with CloudFlare, Inc., which reserves the following IP addresses for talkingmedicines.com: 104.21.51.163, 172.67.182.133. Moreover, DNS used with this website include burt.ns.cloudflare.com, sara.ns.cloudflare.com. Subnet identifier ranges from 104.16.0.0 to 104.31.255.255. Classless Inter-Domain Routing (CIDR) is 104.16.0.0/12. ARIN net type is Direct Allocation.

  • 5 months ago

    Last scanned

  • 9 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

  • Created

    2014-05-18

  • Expires

    2024-05-18

  • Owner

    Registration Private (Domains By Proxy, LLC)

  • Registar

    123-Reg Limited

  • Owner Emails

    DBP@domainsbyproxy.com

Domain & Keywords

The registrar of talkingmedicines.com is 123-Reg Limited and the name expires on 2024-05-18. Owner email is obscured for security reasons, so you cannot reach them directly. Their country of residence is United States of America.

  • ehealth
  • mhealth
  • ehealth definition
  • what is mhealth
  • mhealth apps

Websites similar to talkingmedicines.com